Transition and Separation AgreementTransition and Separation Agreement • June 17th, 2022 • ATAI Life Sciences N.V. • Pharmaceutical preparations • New York
Contract Type FiledJune 17th, 2022 Company Industry JurisdictionThis Transition and Separation Agreement (“Agreement”) is made as of June 15, 2022 (the “Notice Date”), by and among ATAI Life Sciences US, Inc. (the “Company”), ATAI Life Sciences N.V. (“Parent”) and Greg Weaver (the “Executive”) (collectively referred to as the “parties” or individually referred to as a “party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).